ICON PLC (ICLR) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
ICON PLC stock (ICLR) is currently trading at $99.99. ICON PLC PE ratio is 13.65. ICON PLC PS ratio (Price-to-Sales) is 0.97. Analyst consensus price target for ICLR is $138.64. WallStSmart rates ICLR as Underperform.
- ICLR PE ratio analysis and historical PE chart
- ICLR PS ratio (Price-to-Sales) history and trend
- ICLR intrinsic value — DCF, Graham Number, EPV models
- ICLR stock price prediction 2025 2026 2027 2028 2029 2030
- ICLR fair value vs current price
- ICLR insider transactions and insider buying
- Is ICLR undervalued or overvalued?
- ICON PLC financial analysis — revenue, earnings, cash flow
- ICLR Piotroski F-Score and Altman Z-Score
- ICLR analyst price target and Smart Rating
ICON
📊 No data available
Try selecting a different time range
ICLR Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · ICON PLC (ICLR)
ICLR trades 164% above its Graham fair value of $50.46, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
ICON PLC (ICLR) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book, institutional own.. Concerns around peg ratio and return on equity. Fundamentals are solid but monitor weak areas for improvement.
ICON PLC (ICLR) Key Strengths (4)
Paying less than $1 for every $1 of annual revenue
Trading below book value, meaning the market prices it less than net assets
110.05% of shares held by major funds and institutions
Mid-cap company balancing growth potential with stability
Supporting Valuation Data
ICON PLC (ICLR) Areas to Watch (6)
Earnings declining -98.70%, profits shrinking
Very expensive relative to growth, significant premium
Revenue growing slowly at 0.60% annually
Low profitability relative to shareholder equity
Thin operating margins with cost pressures present
Thin profit margins with limited profitability
ICON PLC (ICLR) Detailed Analysis Report
Overall Assessment
This company scores 53/100 in our Smart Analysis, earning a C- grade. Out of 10 metrics analyzed, 4 register as strengths (avg 9.3/10) while 6 fall into concern territory (avg 2.5/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, Price/Book, Institutional Own.. Valuation metrics including Price/Sales (0.97), Price/Book (0.82) suggest the stock is attractively priced.
The Bear Case
The primary concerns are EPS Growth, PEG Ratio, Revenue Growth. Some valuation metrics including PEG Ratio (4.57) suggest expensive pricing. Growth concerns include Revenue Growth at 0.60%, EPS Growth at -98.70%, which may limit upside. Profitability pressure is visible in Return on Equity at 6.27%, Operating Margin at 12.70%, Profit Margin at 7.40%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether EPS Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 6.27% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 0.60% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (Price/Sales, Price/Book) and negatives (EPS Growth, PEG Ratio). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
ICLR Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
ICLR's Price-to-Sales ratio of 0.97x trades at a deep discount to its historical average of 4.17x (2th percentile). The current valuation is 94% below its historical high of 15.57x set in Sep 2006, and 3% above its historical low of 0.94x in Mar 2026.
Compare ICLR with Competitors
Top DIAGNOSTICS & RESEARCH stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for ICON PLC (ICLR) · HEALTHCARE › DIAGNOSTICS & RESEARCH
The Big Picture
ICON PLC operates as a stable business with moderate growth and solid fundamentals. Revenue reached 8.1B with 1% growth year-over-year. Profit margins are thin at 7.4%, typical for companies in this phase that are reinvesting heavily in growth.
Key Findings
Generating 352M in free cash flow and 409M in operating cash flow. Earnings are translating into actual cash generation.
What to Watch Next
Margin expansion: can ICON PLC push profit margins above 15% as the business scales?
Debt management: total debt of 3.6B is significantly higher than cash (469M). Monitor refinancing risk.
Sector dynamics: monitor DIAGNOSTICS & RESEARCH industry trends, competitive moves, and regulatory changes that could impact ICON PLC.
Bottom Line
ICON PLC offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About ICON PLC(ICLR)
NASDAQ
HEALTHCARE
DIAGNOSTICS & RESEARCH
USA
ICON Public Limited Company, a clinical research organization, provides outsourced marketing and development services in Ireland, the rest of Europe, the United States and internationally. The company is headquartered in Dublin, Ireland.